找到关键词“Drug药”相关内容 39搜索耗时:0.2753秒

FTUSA20231120

MONDAY20NOVEMBER2023USA$2.50CanadaC$3.00TheEUisnotthesameonetheUKleftWeightlossDrugsarereshapingbusinessMICHELBARNIERINTERVIEW,PAGE13RANAFOROOHAR,PAGE17PollpositionsBriefingStarkchoicesforArgentina...

时间:2023-12-01 22:52栏目:外刊综合

FTME20231120

MONDAY20NOVEMBER2023MIDDLEEASTTheEUisnotthesameonetheUKleftWeightlossDrugsarereshapingbusinessMICHELBARNIERINTERVIEW,PAGE15RANAFOROOHAR,PAGE19PollpositionsBriefingStarkchoicesforArgentinaiEUandSout...

时间:2023-12-01 22:53栏目:外刊综合

医药行业深度报告:ADC鏖战 引领精准化疗新时代

行[Table_Message2]023-11-02业行业深度报告看好/维持医药研究[Table_Title]医药报告ADC鏖战引领精准化疗新时代◼走势比较[报Ta告b摘le_要Summary]16%10%22/11/1抗体偶联药物(Antibody-Drugconjugate,ADC)是继...

时间:2023-11-07 20:01栏目:综合其他

MIT Technology Review - September-October 2023

Volume126Number5September/October2023Meetthe2023InnovatorsUnder35EricSchmidtontransformingscienceWhenAIgoestowarExperimentalDrugsVolume126Number5September/October2023Meetthe2023InnovatorsUnder35Eri...

时间:2023-09-18 17:43栏目:外刊综合

Bloomberg Businessweek USA - August 28, 2023

○China’slatesthousingmeltdown6○ThelucrativeDrugbenefitsgame8○Howmuchdebtistoomuch?22August28,2023Lymediseasehasexplodedinrecentyears,butanewvaccinemay—nally—beclose36TickTickTickTechnology.Ga...

时间:2023-09-18 17:43栏目:外刊综合

2021新药年度报告-FDA

AdvancingHealthThroughInnovation:NewDrugTherapyApprovals2021IMPACTINNOVATIONPREDICTABILITYACCESSFDA’sCenterforDrugEvaluationandResearchJanuary2022TableofContentsDirector’sMessage....................

时间:2023-09-03 10:16栏目:综合其他

对开发突变体特异性和广谱KRAS抑制剂的策略

924CANCERDISCOVERYAPRIL2022AACRJournals.orgREVIEWExpandingtheReachofPrecisionOncologybyDruggingAllKRASMutantsMarcoH.Hofmann1,DanielGerlach1,SandraMisale2,MarkPetronczki1,andNorbertKraut1ABSTRACTKRA...

时间:2023-09-01 13:59栏目:综合其他

The Times - 9 August 2023

WednesdayAugust92023thetimes.co.ukNo74170Aweight-lossDrugthatcancutheartattacksandstrokesbyafifthhasbeenhailedbythegovernmentasakeytoolineasingpressuresontheNHS.Inalandmarktrialinvolvingmorethan17,...

时间:2023-08-15 08:22栏目:外刊综合

DeepTech发布《2022全球肿瘤免疫疗法技术与行业研究报告》

•NMPA:国家药品监督管理局。•FDA:美国食品药品监督管理局。•CDE:国家药品监督管理局药品评审中心。•IND:新药研究申请(InvestigationalNewDrug),新药临床研究在进行临床实验前,需要进行的研究型新药(...

时间:2023-08-11 22:49栏目:综合其他

2022全球肿瘤免疫疗法技术与行业研究报告

•NMPA:国家药品监督管理局。•FDA:美国食品药品监督管理局。•CDE:国家药品监督管理局药品评审中心。•IND:新药研究申请(InvestigationalNewDrug),新药临床研究在进行临床实验前,需要进行的研究型新药(...

时间:2023-08-11 22:49栏目:综合其他

确认删除?
VIP会员服务
限时9折优惠